EUVIMEDEUVIMED entdecken
Crossref

ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment

瑞鹏 孟

Advances in Clinical Medicine · 2026 · 16 (04) · 4337-4349

DOI: 10.12677/acm.2026.1641702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 瑞鹏 孟. Die Arbeit nennt 65 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

孟, 瑞. (2026). ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment. Advances in Clinical Medicine, 16(04), 4337-4349. https://doi.org/10.12677/acm.2026.1641702

Vancouver

孟 瑞. ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment. Advances in Clinical Medicine. 2026;16(04):4337-4349. doi:10.12677/acm.2026.1641702

BibTeX
@article{2026,
  author = {孟, 瑞鹏},
  title = {ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment},
  journal = {Advances in Clinical Medicine},
  year = {2026},
  volume = {16},
  number = {04},
  pages = {4337--4349},
  doi = {10.12677/acm.2026.1641702}
}
Kostenlos starten →